about
A multi-scale approach to designing therapeutics for tuberculosisDigitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of TuberculosisThe dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.Nanoparticle approaches against bacterial infectionsGenetically diverse mice are novel and valuable models of age-associated susceptibility to Mycobacterium tuberculosis.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionUnderstanding and overcoming the barriers to T cell-mediated immunity against tuberculosisInherited and acquired immunodeficiencies underlying tuberculosis in childhood.Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot StudymicroRNA-17-5p Modulates Bacille Calmette-Guerin Growth in RAW264.7 Cells by Targeting ULK1.Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines.Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice.Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.Heme Oxygenase-1 Regulates Inflammation and Mycobacterial Survival in Human Macrophages during Mycobacterium tuberculosis Infection.Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infectionVaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against H37Rv strain
P2860
Q28647309-AA28ECB6-8A22-4BB9-B03A-89C3E41BFD21Q33654519-A71EAF04-CF35-4D70-B896-BB551BA3A878Q33751671-61CBE68D-D52C-434B-9394-9FA1D2467B7EQ34339159-325DEF76-A9FC-46B9-B4A7-EB9F67719F8FQ34986125-DB280C01-E3CA-4FD8-9C1E-B30F76C1D23AQ35039807-DDA9625C-9172-4D13-B6BA-B7A9F3164E7DQ35039934-A58E2576-5C7B-456C-BCE1-46F654662F48Q35510477-998B331F-8C42-461D-B6B4-56645F560DD8Q35680564-57BEDFC5-6E54-4A4C-8096-B67C4C34A137Q35780533-8A7705AD-307F-4567-A3D1-DA41E6AD0611Q36035900-05C6F639-5367-4516-B2E4-E3D853AAE139Q36090847-D323AD7E-0571-4E2E-BE62-F83392E67806Q36654001-575A7442-6951-4D58-BCED-0F3D6451030EQ37621289-05D3CAB6-1B67-40C5-9A7D-B98E92734A62Q38752400-190B5382-B6D6-4C36-8F9C-E6215789A701Q40673231-9092BC9E-0235-4E78-8E42-974C2AEC9E32Q41596789-600D3B13-B2ED-4026-B193-0F81AFF5F791Q52657152-FE5068D1-2D19-47BF-A365-B24D5A8E5431Q56525852-72AA14E9-794E-4517-9AE5-199E0B2B540B
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
TB or not TB: that is no longer the question.
@en
type
label
TB or not TB: that is no longer the question.
@en
prefLabel
TB or not TB: that is no longer the question.
@en
P2860
P1476
TB or not TB: that is no longer the question.
@en
P2093
Barry R Bloom
P2860
P304
P356
10.1126/SCITRANSLMED.3007402
P407
P577
2013-11-01T00:00:00Z